Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

R1 RCM Inc. RCM NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
53/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$17.11
+19.6%

R1 RCM Inc. (RCM) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $14.31. It has a SharesGrow Score of 53/100, indicating a mixed investment profile with 0 out of 7 criteria passed.

Analyst consensus target is RCM = $17 (+19.6% upside).

Financials: revenue is $2.3B, +21.1%/yr average growth. Net income is $3M, growing at -28.2%/yr. Net profit margin is 0.1% (thin). Gross margin is 21.5% (+1.9 pp trend).

Balance sheet: total debt is $1.7B against $2.8B equity (Debt-to-Equity (D/E) ratio 0.63, moderate). Current ratio is 1.83 (strong liquidity). Debt-to-assets is 35.1%. Total assets: $5.0B.

Analyst outlook: 13 / 22 analysts rate RCM as buy (59%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 48/100 (Partial), Growth 58/100 (Partial), Past 75/100 (Partial), Health 50/100 (Partial), Moat 49/100 (Partial), Future 58/100 (Partial), Income 30/100 (Fail).

$17.11
▲ 19.57% Upside
Average Price Target
Based on 22 Wall Street analysts offering 12-month price targets for R1 RCM Inc., the average price target is $17.11, with a high forecast of $25.00, and a low forecast of $14.00.
Highest Price Target
$25.00
Average Price Target
$17.11
Lowest Price Target
$14.00

RCM SharesGrow Score Overview

53/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 48/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 75/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 49/100
Gross margin is + market cap
FUTURE 58/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — RCM

~
VALUE Partial
48/100
RCM trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $17, implying +18.8% from the current price $14. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
RCM: +21.1%/yr revenue is, -28.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
75/100
RCM: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet RCM: Debt-to-Equity (D/E) ratio 0.63 (moderate), Current ratio is 1.83 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
49/100
RCM: Gross margin is 21.5% (+1.9 pp trend), $6B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 49/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
58/100
Analyst outlook: 13 / 22 analysts rate RCM as buy (59%). Analyst consensus target is $17 (+18.8% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
30/100
RCM: Net profit margin is 0.1%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
Market Cap$6.04B
Beta (1Y)0.84
Share Statistics
EPS (TTM)0.01
Shares Outstanding$418.59M
IPO Date2017-03-16
Employees29,400
CEOLee Rivas
Financial Highlights & Ratios
Revenue (TTM)$2.25B
Gross Profit$484.5M
EBITDA$436.3M
Net Income$3.3M
Operating Income$147.9M
Total Cash$173.6M
Total Debt$1.74B
Net Debt$1.57B
Total Assets$4.96B
Price / Earnings (P/E)1811.4
Price / Sales (P/S)2.68
Analyst Forecast
1Y Price Target$15.15
Target High$25.00
Target Low$14.00
Upside+5.9%
Rating ConsensusBuy
Analysts Covering22
Buy 59% Hold 41% Sell 0%
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS77634L1052

Price Chart

Track all markets on TradingView
RCM
R1 RCM Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Healthcare Information Services

People Also View

HQY
HQY
HealthEquity, Inc.
$81.36
+1.81%
 PRVA
PRVA
Privia Health Group, Inc.
$23.12
+0.48%
 NXGN
NXGN
NextGen Healthcare, Inc.
$23.94
+0.13%
 AGTI
AGTI
Agiliti, Inc.
$10.05
-0.50%
 CERT
CERT
Certara, Inc.
$5.82
+0.52%
 MDRX
MDRX
Veradigm Inc.
$4.49
+6.65%
 HSTM
HSTM
HealthStream, Inc.
$20.34
-0.15%
 NRC
NRC
National Research Corporation
$17.04
+1.34%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message